USP53 and neoplastic disease or syndrome: Recent work by Xia et al. further summarized emerging evidence that, although catalytically inactive, USP53 exerts significant physiological and pathological roles across multiple tissues, acting as a novel regulatory protein and a potential diagnostic and therapeutic target in metabolic, skeletal, hepatic, and neoplastic disorders (Xia et al., 2024).